Indegene Limited

NSE INDGN.NS

Indegene Limited Operating Income Margin for the year ending March 31, 2024: 33.78%

Indegene Limited Operating Income Margin is 33.78% for the year ending March 31, 2024, a 105.30% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Indegene Limited Operating Income Margin for the year ending March 31, 2023 was 16.45%, a 0.13% change year over year.
  • Indegene Limited Operating Income Margin for the year ending March 31, 2022 was 16.43%, a -29.66% change year over year.
  • Indegene Limited Operating Income Margin for the year ending March 31, 2021 was 23.36%, a 20.30% change year over year.
  • Indegene Limited Operating Income Margin for the year ending March 31, 2020 was 19.42%.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
NSE: INDGN.NS

Indegene Limited

CEO Mr. Manish Gupta BTech, MBA
IPO Date May 13, 2024
Location India
Headquarters Manyata Embassy Business Park
Employees 4,367
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Indegene Limited operates as a life sciences commercialization company in India and internationally. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get to the market, and grow impact through the life cycle. The company offers enterprise commercial solutions, enterprise medical solutions, enterprise clinical solutions, omnichannel activation solutions, and NEXT technology platforms. The company was incorporated in 1998 and is based in Bengaluru, India.

StockViz Staff

January 15, 2025

Any question? Send us an email